How severe is CVE-2022-36775?

CVE-2022-36775 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2022-36775 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (34th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-36775?

CVE-2022-36775 primarily affects Ibm Security Verify Access. In total, 10 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2022-36775?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2022-36775 published?

CVE-2022-36775 was published on 2023-02-17 and last updated on 2026-06-17.

CVE-2022-36775

CVE-2022-36775 is a medium-severity vulnerability in Ibm Security Verify Access with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
EPSS exploit prediction: 0% (34th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-74
Affected product: Ibm Security Verify Access
Published: 2023-02-17
Last modified: 2026-06-17

Description

IBM Security Verify Access 10.0.0.0, 10.0.1.0, 10.0.2.0, 10.0.3.0, and10.0.4.0 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers. This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking. IBM X-Force ID: 233576.

Frequently asked questions

What is CVE-2022-36775?: IBM Security Verify Access 10.0.0.0, 10.0.1.0, 10.0.2.0, 10.0.3.0, and10.0.4.0 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers. This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking. IBM X-Force ID: 233576.
How severe is CVE-2022-36775?: CVE-2022-36775 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2022-36775 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (34th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-36775?: CVE-2022-36775 primarily affects Ibm Security Verify Access. In total, 10 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2022-36775?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-36775 published?: CVE-2022-36775 was published on 2023-02-17 and last updated on 2026-06-17.

References

Affected products (10)

cpe:2.3:a:ibm:security_verify_access:10.0.0.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access:10.0.1.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access:10.0.2.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access:10.0.3.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access:10.0.4.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access_docker:10.0.0.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access_docker:10.0.1.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access_docker:10.0.2.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access_docker:10.0.3.0:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_verify_access_docker:10.0.4.0:*:*:*:*:*:*:*

More vulnerabilities in Ibm Security Verify Access

CVE-2024-49803 — Critical (CVSS 9.8): IBM Security Verify Access Appliance 10.0.0 through 10.0.8 could allow a remote authenticated attacker to execute…
CVE-2021-39070 — Critical (CVSS 9.8): IBM Security Verify Access 10.0.0.0, 10.0.1.0 and 10.0.2.0 with the advanced access control authentication service…
CVE-2020-4499 — Critical (CVSS 9.8): IBM Security Access Manager 9.0.7 and IBM Security Verify Access 10.0.0 could allow an unauthorized public Oauth client…
CVE-2024-49806 — Critical (CVSS 9.4): IBM Security Verify Access Appliance 10.0.0 through 10.0.8 contains hard-coded credentials, such as a password or…
CVE-2024-49805 — Critical (CVSS 9.4): IBM Security Verify Access Appliance 10.0.0 through 10.0.8 contains hard-coded credentials, such as a password or…
CVE-2026-1346 — Critical (CVSS 9.3): IBM Verify Identity Access Container 11.0 through 11.0.2 and IBM Security Verify Access Container 10.0 through 10.0.9.1…

All CVEs affecting Ibm Security Verify Access →

Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities

CVE-2026-25586 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.29, a sandbox escape is possible by shadowing hasOwnProperty…
CVE-2026-25520 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.29, The return values of functions aren't wrapped.…
CVE-2025-20265 — Critical (CVSS 10.0): A vulnerability in the RADIUS subsystem implementation of Cisco Secure Firewall Management Center (FMC) Software could…
CVE-2025-20337 — Critical (CVSS 10.0): A vulnerability in a specific API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
CVE-2025-20281 — Critical (CVSS 10.0): A vulnerability in a specific API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
CVE-2024-42472 — Critical (CVSS 10.0): Flatpak is a Linux application sandboxing and distribution framework. Prior to versions 1.14.0 and 1.15.10, a malicious…

Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →